Orchestra BioMed files 8-K/A to correct prior investor presentation

Orchestra BioMed Holdings, Inc.

Amendment corrects the investor presentation originally filed on July 12, 2023; revised Exhibit 99.1 supersedes prior version.
No other changes to the original 8-K; the correction is not specified in the filing.
Revised presentation is used at investor conferences and posted on the company's website.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.